Thin film drugs are relatively new form of drugs that includes encapsulation of tablets or capsules with thin polymer coating. These drugs rapidly dissolves when placed in the buccal cavity resulting in fast systemic circulation. Major pharmaceutical companies are switching their traditional tablets to drugs with fast dissolving oral thin films. These drugs eliminates the problems of swallowing among geriatric and pediatric patients.
The thin film drugs market is anticipated to grow in the forecast, owing to lower manufacturing costs of these drugs, increasing adoption of thin film drugs and various advantages offered by the dosage forms. In addition, the efforts towards improving therapeutic outputs of the drugs is expected to offer significant growth opportunities in the market during the forecast period.
The "Global Thin Film Drugs Market Analysis to 2027" is a specialized and in-depth study of the medical device industry with a special focus on the global market trend analysis. The report aims to provide an overview of thin film drugs market with detailed market segmentation by drug type, disease indication and geography. The global thin film drugs market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading thin film drugs market players and offers key trends and opportunities in the market.
The global thin film drugs market is segmented on the basis of drug type and disease indication. Based on drug type, the market is segmented as oral thin film, transdermal thin film and others. Based on disease indication, the market is segmented into schizophrenia, migraine, opioid dependence, nausea & vomiting, others.
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the global thin film drugs market based on various segments. It also provides market size and forecast estimates from year 2017 to 2027 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The thin film drugs market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.
The report analyzes factors affecting thin film drugs market from both demand and supply side and further evaluates market dynamics effecting the market during the forecast period i.e., drivers, restraints, opportunities and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the thin film drugs market in these regions.
The reports cover key developments in the thin film drugs market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies activities witnessed in the market were acquisitions and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market payers from thin film drugs market are anticipated to lucrative growth opportunities in the future with the rising demand for thin film drugs market in the global market. Below mentioned is the list of few companies engaged in the thin film drugs market.
The report also includes the profiles of key thin film drugs market companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.
- Pfizer, Inc.
- ZIM Laboratories Limited
- Novartis AG
- Wolters Kluwer
- Allergan plc
- Sumitomo Dainippon Pharma Co., Ltd.
- IntelGenx Corp.
- Indivior plc
- MonoSol Rx
The Insight Partner's dedicated research and analysis team consist of experienced professionals with advanced statistical expertise and offer various customization options in the existing study.